Please join our March 21 community call (11 am ET) to hear about five recent publications from the OHDSI community. We will hear about the following studies from the listed publication leads:
-
Rates of Antipsychotic Drug Prescribing Among People Living With Dementia During the COVID-19 Pandemic (b, Assistant Professor, University of Hong Kong)
-
Safety outcomes of selective serotonin reuptake inhibitors in adolescent attention-deficit/hyperactivity disorder with comorbid depression: the ASSURE study (Chungsoo Kim, PhD Candidate, Department of Biomedical Informatics, Ajou University)
-
Risk of COVID-19 Diagnosis and Hospitalisation in Patients with Osteoarthritis or Back Pain Treated with Ibuprofen Compared to Other NSAIDs or Paracetamol: A Network Cohort Study (Junqing (Frank) Xie, DPhil Student & Research Assistant, University of Oxford)
-
An ETL-process design for data harmonization to participate in international research with German real-world data based on FHIR and OMOP CDM (Yuan Peng, Research Fellow, Technische Universität Dresden)
-
Integrating real-world data to assess cardiac ablation device outcomes in a multicenter study using the OMOP common data model for regulatory decisions: implementation and evaluation (Yue Yu, Senior Bioinformatician, Department of Quantitative Health Sciences, Mayo Clinic)
Everybody is invited. Calendar invites went out earlier today. If you did not receive one, please use this link to join the meeting. All recordings from these weekly calls will be posted on both our main OHDSI Teams tenant and on our OHDSI.org Community Calls page.
